Home News & Events Events Events Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Industry WRIB Date 13 April 2026 - 17 April 2026 Time 08:00 - 18:00 Location Dallas, TX, USA Timezone America/Chicago ICON will exhibit and speak | Booth #31 Industry AMCP Date 13 April 2026 - 16 April 2026 Time 08:00 - 18:00 Location Nashville, TN, USA Timezone America/Chicago ICON will exhibit | Booth #1412 Industry GLP-1 Based Therapeutics Summit Date 15 April 2026 - 16 April 2026 Time 08:00 - 18:00 Location Boston, MA, USA Timezone America/New York ICON will sponsor and speak Industry CTO West Coast Date 28 April 2026 - 29 April 2026 Time 08:00 - 18:00 Location San Francisco, CA, USA Timezone America/Los Angeles ICON will exhibit and speak | Booth #2 Industry SCDM EMEA Date 3 May 2026 - 6 May 2026 Time 08:00 - 18:00 Location Copenhagen, Denmark Timezone Europe/Copenhagen ICON will exhibit and speak Industry RAPS Euro Convergence Date 5 May 2026 - 8 May 2026 Time 08:00 - 18:00 Location Lisbon, Portugal Timezone Europe/Lisbon ICON will exhibit | Booth #21 Industry OCT Europe Date 6 May 2026 - 7 May 2026 Time 08:00 - 18:00 Location Barcelona, Spain Timezone Europe/Madrid CON will exhibit and speak Booth #52 Industry Bio Middle East Date 11 May 2026 - 13 May 2026 Time 08:00 - 18:00 Location Riyadh, Saudi Arabia Timezone Asia/Aden ICON will speak Industry AAPS NBC Date 11 May 2026 - 14 May 2026 Time 08:00 - 18:00 Location San Diego, CA, USA Timezone America/Los Angeles ICON will exhibit | Booth #404 Previous 1 2 3 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Join us to explore the latest best practices in global flow cytometry QC and harmonisation. During this webinar hosted by Bioanalysis Zone ICON’s flow cytometry specialists will discuss: - Industry best practices for h... 8h View post View webpage ICON Plc In recognition of Rare Disease Day, join ICON’s Centre for Rare Diseases for an inspiring panel at our upcoming webinar on 3 March at 11 am EST. Hear directly from parent and patient leaders whose advocacy is driving f... 24 Feb View post View webpage ICON Plc 2025 signalled a reset for global biotech, with capital discipline, shifting partnership models and sharper execution shaping the year. Asia’s expanding R&D footprint further underlined the sector’s geographic diversific... 24 Feb View post View webpage ICON Plc The EU Joint Clinical Assessment is already influencing how oncology therapies are developed and assessed across Europe. In this article, Dr. Liz O’Brien of ICON explains how #JCA is driving earlier evidence generation, ... 24 Feb 2 View post View webpage ICON Plc Formulations in early clinical development require a delicate balance of flexibility, simplicity, and scientific rigor. In first‑in‑human trials, dose ranges can vary by 10–100 fold increase between the starting dose a... 23 Feb View post View webpage ICON Plc Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe... 23 Feb View post View webpage ICON Plc Non-invasive testing could transform the management of metabolic liver disease and help shape the future of MASH clinical development. This article in SelectScience® explores the evolving NIT landscape, emerging regulat... 20 Feb View post View webpage ICON Plc New analyses show that well-implemented DHTs can: - Reduce trial timelines by 3–5 months - Decrease enrollment requirements by up to 16% - Lower protocol amendment risk - Deliver meaningful ROI in both Phase II and Phase... 19 Feb View post View webpage ICON Plc Come along to Rüdiger Kaspera's Learning Lab at ASCPT, where he’ll dive into science and risk based strategies for designing oligonucleotide First‑in‑Human studies - covering toxicity, study design, PK/PD, population se... 18 Feb View post View webpage ICON Plc Patient led organisations are shaping scientific and regulatory strategy in ultra rare diseases. Join our live panel as we bring together leaders whose work has contributed to gene therapies, accelerated approvals and ... 18 Feb View post View webpage
